Hypolipidemic activity of boronated nucleosides and nucleotides in rodents.
Biomed Pharmacother
; 47(2-3): 79-87, 1993.
Article
en En
| MEDLINE
| ID: mdl-8218953
ABSTRACT
Base-boronated nucleoside and phosphate-boronated nucleotides were potent hypolipidemic agents in rodents, lowering both serum cholesterol and triglyceride levels. Rat VLDL and LDL cholesterol levels were generally reduced and HDL cholesterol levels were significantly elevated after 14 days dosing at 8 mg/kg/day. Tissue cholesterol, triglyceride and phospholipid levels were reduced by selected derivatives. Increased fecal excretion of lipids did not appear to be a mechanism by which these derivatives lowered serum lipids in rodents. Rather, the agents suppressed appetite and reduced the activities of rate-limiting enzymes for de novo lipid synthesis, specifically cytoplasmic acetyl CoA synthetase, squalene synthetase, and phosphatidylate phosphohydrolase with IC50 values of approximately 10(-5) m.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Roedores
/
Compuestos de Boro
/
Hipolipemiantes
/
Nucleósidos
/
Nucleótidos
Límite:
Animals
Idioma:
En
Revista:
Biomed Pharmacother
Año:
1993
Tipo del documento:
Article